Trade Summary

Yesterday, Schmid John P., serving as Dir at BlossomHill Therapeutics, Inc. (BLSM), purchased 6,000 shares at $16.00 per share, for a total transaction value of $96,000.00. Following this transaction, Schmid John P. now holds 6,000 shares of BLSM.

The trade was executed on Monday, August 10, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 10, 2026 at 6:35 PM ET, meaning the disclosure happened on the same day as the trade.

BlossomHill Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.